| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-152 |
Sentence |
denotes |
Rapid and sensitive GC/MS characterization of glycolipid released Galalpha1,3Gal-terminated oligosaccharides from small organ specimens of a single pig. |
| T1 |
0-152 |
Sentence |
denotes |
Rapid and sensitive GC/MS characterization of glycolipid released Galalpha1,3Gal-terminated oligosaccharides from small organ specimens of a single pig. |
| T1 |
0-152 |
Sentence |
denotes |
Rapid and sensitive GC/MS characterization of glycolipid released Galalpha1,3Gal-terminated oligosaccharides from small organ specimens of a single pig. |
| TextSentencer_T2 |
153-297 |
Sentence |
denotes |
Pig to human xenotransplantation is considered a possible solution to the prevailing chronic lack of human donor organs for allotransplantation. |
| T2 |
153-297 |
Sentence |
denotes |
Pig to human xenotransplantation is considered a possible solution to the prevailing chronic lack of human donor organs for allotransplantation. |
| T2 |
153-297 |
Sentence |
denotes |
Pig to human xenotransplantation is considered a possible solution to the prevailing chronic lack of human donor organs for allotransplantation. |
| TextSentencer_T3 |
298-457 |
Sentence |
denotes |
The Galalpha1,3Gal determinant is the major porcine xenogeneic epitope causing hyperacute rejection following human antibody binding and complement activation. |
| T3 |
298-457 |
Sentence |
denotes |
The Galalpha1,3Gal determinant is the major porcine xenogeneic epitope causing hyperacute rejection following human antibody binding and complement activation. |
| T3 |
298-457 |
Sentence |
denotes |
The Galalpha1,3Gal determinant is the major porcine xenogeneic epitope causing hyperacute rejection following human antibody binding and complement activation. |
| TextSentencer_T4 |
458-788 |
Sentence |
denotes |
In order to characterize the tissue distribution of Galalpha1,3Gal-containing and blood group-type glycosphingolipids in pig, acid and nonacid glycosphingolipids were isolated from the kidney, small intestine, spleen, salivary gland, liver, and heart of a single pig obtained from a semi-inbred strain homozygous at the SLA locus. |
| T4 |
458-788 |
Sentence |
denotes |
In order to characterize the tissue distribution of Galalpha1,3Gal-containing and blood group-type glycosphingolipids in pig, acid and nonacid glycosphingolipids were isolated from the kidney, small intestine, spleen, salivary gland, liver, and heart of a single pig obtained from a semi-inbred strain homozygous at the SLA locus. |
| T4 |
458-788 |
Sentence |
denotes |
In order to characterize the tissue distribution of Galalpha1,3Gal-containing and blood group-type glycosphingolipids in pig, acid and nonacid glycosphingolipids were isolated from the kidney, small intestine, spleen, salivary gland, liver, and heart of a single pig obtained from a semi-inbred strain homozygous at the SLA locus. |
| TextSentencer_T5 |
789-1076 |
Sentence |
denotes |
Glycolipids were analyzed by thin-layer immunostaining using monoclonal antibodies, and following ceramide glycanase cleavage as permethylated oligosaccharides by gas chromatography, gas chromatography-mass spectrometry, and matrix-assisted laser desorption/ionization mass spectrometry. |
| T5 |
789-1076 |
Sentence |
denotes |
Glycolipids were analyzed by thin-layer immunostaining using monoclonal antibodies, and following ceramide glycanase cleavage as permethylated oligosaccharides by gas chromatography, gas chromatography-mass spectrometry, and matrix-assisted laser desorption/ionization mass spectrometry. |
| T5 |
789-1076 |
Sentence |
denotes |
Glycolipids were analyzed by thin-layer immunostaining using monoclonal antibodies, and following ceramide glycanase cleavage as permethylated oligosaccharides by gas chromatography, gas chromatography-mass spectrometry, and matrix-assisted laser desorption/ionization mass spectrometry. |
| TextSentencer_T6 |
1077-1276 |
Sentence |
denotes |
The kidney contained large amounts of Galalpha1,3Gal-containing penta- and hexasaccharides having carbohydrate sequences consistent with the Galalpha1,3nLc4and Galalpha1,3Lexstructures, respectively. |
| T6 |
1077-1276 |
Sentence |
denotes |
The kidney contained large amounts of Galalpha1,3Gal-containing penta- and hexasaccharides having carbohydrate sequences consistent with the Galalpha1,3nLc4and Galalpha1,3Lexstructures, respectively. |
| T6 |
1077-1276 |
Sentence |
denotes |
The kidney contained large amounts of Galalpha1,3Gal-containing penta- and hexasaccharides having carbohydrate sequences consistent with the Galalpha1,3nLc4and Galalpha1,3Lexstructures, respectively. |
| TextSentencer_T7 |
1277-1348 |
Sentence |
denotes |
The former structure was tentatively identified in all organs by GC/MS. |
| T7 |
1277-1348 |
Sentence |
denotes |
The former structure was tentatively identified in all organs by GC/MS. |
| T7 |
1277-1348 |
Sentence |
denotes |
The former structure was tentatively identified in all organs by GC/MS. |
| TextSentencer_T8 |
1349-1546 |
Sentence |
denotes |
The presence of extended Galalpha1,3Gal-terminated structures in the kidney and heart was suggested by antibody binding, and GC/MS indicated the presence of a Galalpha1,3nLc6structure in the heart. |
| T8 |
1349-1546 |
Sentence |
denotes |
The presence of extended Galalpha1,3Gal-terminated structures in the kidney and heart was suggested by antibody binding, and GC/MS indicated the presence of a Galalpha1,3nLc6structure in the heart. |
| T8 |
1349-1546 |
Sentence |
denotes |
The presence of extended Galalpha1,3Gal-terminated structures in the kidney and heart was suggested by antibody binding, and GC/MS indicated the presence of a Galalpha1,3nLc6structure in the heart. |
| TextSentencer_T9 |
1547-1737 |
Sentence |
denotes |
The kidney, spleen, and heart contained blood group H pentaglycosylceramides based on type 1 (H-5-1) and type 2 (H-5-2) chains, and H hexaglycosylceramides based on the type 4 chain (H-6-4). |
| T9 |
1547-1737 |
Sentence |
denotes |
The kidney, spleen, and heart contained blood group H pentaglycosylceramides based on type 1 (H-5-1) and type 2 (H-5-2) chains, and H hexaglycosylceramides based on the type 4 chain (H-6-4). |
| T9 |
1547-1737 |
Sentence |
denotes |
The kidney, spleen, and heart contained blood group H pentaglycosylceramides based on type 1 (H-5-1) and type 2 (H-5-2) chains, and H hexaglycosylceramides based on the type 4 chain (H-6-4). |
| TextSentencer_T10 |
1738-1887 |
Sentence |
denotes |
In the intestine H-5-1 and H-6-4 were expressed, in the salivary gland H-5-1 and H-5-2, whereas only the H-5-1 structure was identified in the liver. |
| T10 |
1738-1887 |
Sentence |
denotes |
In the intestine H-5-1 and H-6-4 were expressed, in the salivary gland H-5-1 and H-5-2, whereas only the H-5-1 structure was identified in the liver. |
| T10 |
1738-1887 |
Sentence |
denotes |
In the intestine H-5-1 and H-6-4 were expressed, in the salivary gland H-5-1 and H-5-2, whereas only the H-5-1 structure was identified in the liver. |
| TextSentencer_T11 |
1888-2074 |
Sentence |
denotes |
Blood group A structures were identified in the salivary gland and the heart by antibody binding and GC/MS, indicating an organ-specific expression of blood group AH antigens in the pig. |
| T11 |
1888-2074 |
Sentence |
denotes |
Blood group A structures were identified in the salivary gland and the heart by antibody binding and GC/MS, indicating an organ-specific expression of blood group AH antigens in the pig. |
| T11 |
1888-2074 |
Sentence |
denotes |
Blood group A structures were identified in the salivary gland and the heart by antibody binding and GC/MS, indicating an organ-specific expression of blood group AH antigens in the pig. |